Evoq Remedies Q2 Results
- BSE: 543500
- NSE: -
- ISIN: INE0JVD01011
- Sector: Biotechnology & Drugs
BSE
4.69
0.09 (1.96%)
0.09 (1.96%)Volume20.00 K
Updated: Fri 13 Jun, 2025 | 12:15:00
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Evoq Remedies Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | - | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | - | N/A | 3.90 | 0.00% |
| Selling/ General/ Admin Expenses Total | 0.02 | - | N/A | 0.06 | -72.23% |
| Depreciation/ Amortization | 0.00 | - | N/A | 0.00 | -11.11% |
| Other Operating Expenses Total | 1.61 | - | N/A | 1.47 | 9.77% |
| Total Operating Expense | 1.64 | - | N/A | 3.83 | -57.35% |
| Operating Income | -1.64 | - | N/A | 0.07 | 0.00% |
| Net Income Before Taxes | -1.62 | - | N/A | 0.07 | 0.00% |
| Net Income | -1.62 | - | N/A | 0.05 | 0.00% |
| Diluted Normalized EPS | -0.65 | - | N/A | 0.04 | 0.00% |